Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Global Blood Therapeutics (GBT) News Today

Global Blood Therapeutics logo
GBT Technologies to acquire Nexus Workspaces from CGI
Amex GBT to Acquire CWT for $570 Million
Should we pay people for donating blood?
GBT Technologies Cancels and Voids Reverse Stock Split
PFE Mar 2024 32.500 call
The Global Non-insulin Diabetes Therapeutics Market
GBT IP Technology Portfolio and Other Updates
Get Global Blood Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GBT and its competitors with MarketBeat's FREE daily newsletter.

2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisis (Ad)

Dan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.

Click here to see Dan's full warning to the public.

GBT Media Mentions By Week

GBT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GBT
News Sentiment

0.52

0.60

Average
Medical
News Sentiment

GBT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GBT Articles
This Week

0

0

GBT Articles
Average Week

Get Global Blood Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GBT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:GBT) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners